- A serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), also
known as a
triple releasing agent (TRA), is a type of drug
which induces the release...
-
releasing agent (
SNDRA), and weak RIMA
Etryptamine [α-Ethyltryptamine (αET)] (Monase) – non-selective
serotonin receptor agonist,
SNDRA, and weak RIMA Indeloxazine...
-
derivative which acts as a serotonin-norepinephrine-dopamine
releasing agent (
SNDRA) and
produces stimulant effects.
Another related compound is para-bromomethamphetamine...
-
appears to act as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA),
although it is
significantly less
potent than MDMA.
Montgomery T, Buon...
- (PCA). It is a
potent serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). 2,4-Dichloroamphetamine (2,4-DCA) 3,4-Dichloroamphetamine (3,4-DCA)...
- (e.g., 5-chloro-αMT) Serotonin–norepinephrine–dopamine
releasing agent (
SNDRA) (e.g., MDMA) The
differences in
selectivity of MRAs is the
result of different...
- 4-CMC
mainly acts as a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA), and
partially as a serotonin-norepinephrine-dopamine
reuptake inhibitor...
- pharmacology, MDA is a serotonin–norepinephrine–dopamine
releasing agent (
SNDRA). In most countries, the drug is a
controlled substance and its possession...
- and methamphetamine, serotonin–norepinephrine–dopamine
releasing agents (
SNDRAs) like MDMA and mephedrone, and serotonin–dopamine
releasing agents (SDRAs)...
- in
SDRAs relative to serotonin-norepinephrine-dopamine
releasing agents (
SNDRAs) such as
naphthylisopropylamine (PAL-287). However,
SDRAs like PAL-542 would...
